Search research articles
Contact Us
Filters
Showing results (131-140 of 170) with videos related to
Page
of 17
Sort By:
Frontiers in Oncology
|
August 9, 2020
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus
Concetta Sciammarella, Amalia Luce, Ferdinando Riccardi, et al.
Neuromuscular Disorders : NMD
|
September 14, 2023
Profile of cognitive abilities in spinal muscular atrophy type II and III: what is the role of motor impairment?
Bianca Buchignani, Gianpaolo Cicala, Federica Moriconi, et al.
Journal of Clinical Medicine
|
January 21, 2023
A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable?
Daniela P R Chieffo, Federica Moriconi, Marika Pane, et al.
Oncogene
|
September 27, 2018
BRAF fusions identified in melanomas have variable treatment responses and phenotypes
Jacqueline A Turner, Judson G T Bemis, Stacey M Bagby, et al.
Kidney International
|
August 26, 2019
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine
Anna Capasso, Ariella Benigni, Umberto Capitanio, et al.
Cancer Chemotherapy and Pharmacology
|
June 16, 2018
Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors
Colin D Weekes, Lee S Rosen, Anna Capasso, et al.
BMC Cancer
|
November 5, 2020
RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer
John J Tentler, Julie Lang, Anna Capasso, et al.
International Journal of Cancer
|
May 1, 2013
Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells
Erika Martinelli, Teresa Troiani, Elena D'Aiuto, et al.
BMC Cancer
|
February 7, 2018
Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer
Peter J Klauck, Stacey M Bagby, Anna Capasso, et al.
Annals of Clinical and Translational Neurology
|
April 17, 2026
Safety and Tolerability of Givinostat: Evidence From Real-World and Clinical Practice
Marika Pane, Anna Capasso, Chiara Arpaia, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 170) with videos related to
Sort By:
Page
of 17
Frontiers in Oncology
|
August 9, 2020
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus
Concetta Sciammarella, Amalia Luce, Ferdinando Riccardi, et al.
Neuromuscular Disorders : NMD
|
September 14, 2023
Profile of cognitive abilities in spinal muscular atrophy type II and III: what is the role of motor impairment?
Bianca Buchignani, Gianpaolo Cicala, Federica Moriconi, et al.
Journal of Clinical Medicine
|
January 21, 2023
A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable?
Daniela P R Chieffo, Federica Moriconi, Marika Pane, et al.
Oncogene
|
September 27, 2018
BRAF fusions identified in melanomas have variable treatment responses and phenotypes
Jacqueline A Turner, Judson G T Bemis, Stacey M Bagby, et al.
Kidney International
|
August 26, 2019
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine
Anna Capasso, Ariella Benigni, Umberto Capitanio, et al.
Cancer Chemotherapy and Pharmacology
|
June 16, 2018
Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors
Colin D Weekes, Lee S Rosen, Anna Capasso, et al.
BMC Cancer
|
November 5, 2020
RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer
John J Tentler, Julie Lang, Anna Capasso, et al.
International Journal of Cancer
|
May 1, 2013
Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells
Erika Martinelli, Teresa Troiani, Elena D'Aiuto, et al.
BMC Cancer
|
February 7, 2018
Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer
Peter J Klauck, Stacey M Bagby, Anna Capasso, et al.
Annals of Clinical and Translational Neurology
|
April 17, 2026
Safety and Tolerability of Givinostat: Evidence From Real-World and Clinical Practice
Marika Pane, Anna Capasso, Chiara Arpaia, et al.
Page
of 17